BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32833542)

  • 1. m
    Wang Q; Zhang Q; Huang Y; Zhang J
    DNA Cell Biol; 2020 Oct; 39(10):1767-1778. PubMed ID: 32833542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and immunological characterization of RNA m
    Wang Q; Zhang Q; Li Q; Zhang J; Zhang J
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1547. PubMed ID: 33225598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomics analysis identifies key genes and pathways related to N6-methyladenosine RNA modification in ovarian cancer.
    Xu H; Li X; Wang S; Li F; Gao J; Yan L; Zhu L
    Epigenomics; 2021 Sep; 13(17):1359-1383. PubMed ID: 34550011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Investigation of mRNA
    Jiang M; Lu Y; Duan D; Wang H; Man G; Kang C; Abulimiti K; Li Y
    Dis Markers; 2020; 2020():8833438. PubMed ID: 33273988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions and prognostic values of m
    Liu Y; Guo X; Zhao M; Ao H; Leng X; Liu M; Wu C; Ma J; Zhu J
    J Cell Physiol; 2020 Sep; 235(9):6043-6057. PubMed ID: 32052446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress of N1-methyladenosine RNA modification in cancer.
    Liu Y; Zhang S; Gao X; Ru Y; Gu X; Hu X
    Cell Commun Signal; 2024 Jan; 22(1):79. PubMed ID: 38291517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N
    Wang Q; Guo X; Li L; Gao Z; Su X; Ji M; Liu J
    Cell Death Dis; 2020 Oct; 11(10):911. PubMed ID: 33099572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of m
    Huang W; Kong F; Li R; Chen X; Wang K
    Front Oncol; 2022; 12():827956. PubMed ID: 35155260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA m1A Methyltransferase TRMT6 Predicts Poorer Prognosis and Promotes Malignant Behavior in Glioma.
    Wang B; Niu L; Wang Z; Zhao Z
    Front Mol Biosci; 2021; 8():692130. PubMed ID: 34631793
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
    Zheng Q; Yu X; Zhang Q; He Y; Guo W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells.
    Zou R; Chen X; Jin X; Li S; Ou R; Xue J; Yan X; Chen L; Hu Y; Zhu H
    Surg Oncol; 2018 Jun; 27(2):306-313. PubMed ID: 29937186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer.
    Cheng Y; Wang M; Zhou J; Dong H; Wang S; Xu H
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33808751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA m
    Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
    J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of METTL14 mediates the elevation of PERP mRNA N
    Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
    Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.